OQS
TARS icon

Occudo Quantitative Strategies’s Tarsus Pharmaceuticals TARS Stock Holding History

Occudo Quantitative Strategies’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87M Buy
29,659
+4,990
+20% +$319K 0.1% 289
2026
Q1 		$1.57M Buy
24,669
+15,913
+182% +$1.11M 0.09% 319
2025
Q4 		$717K Buy
+8,756
New +$654K 0.05% 367
2025
Q3 		– Sell
-11,905
Closed -$482K – 863
2025
Q2 		$482K Buy
11,905
+6,677
+128% +$300K 0.05% 357
2025
Q1 		$270K Buy
+5,228
New +$258K 0.04% 498
2023
Q4 		– Sell
-43,707
Closed -$777K – 1183
2023
Q3 		$777K Buy
+43,707
New +$773K 0.1% 350

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Occudo Quantitative Strategies's TARS Position: Q2 2026 in Review

Occudo Quantitative Strategies increased its Tarsus Pharmaceuticals (TARS) stake by 20% in Q2 2026, buying an estimated $319K and bringing the position to 29,659 shares worth $1.87M. The position accounts for 0.1% of the portfolio, ranked #289.

Occudo Quantitative Strategies first reported a position in TARS in Q3 2023 and has held it in 6 quarters since. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Occudo Quantitative Strategies held 29,659 shares of Tarsus Pharmaceuticals worth $1.87M as of Q2 2026.
  • Occudo Quantitative Strategies bought 4,990 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $319K.
  • Tarsus Pharmaceuticals made up 0.1% of Occudo Quantitative Strategies's portfolio in Q2 2026, its #289 holding.
  • Occudo Quantitative Strategies first reported a position in Tarsus Pharmaceuticals in Q3 2023 and has held it in 6 quarters since.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.